{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Vigeland MD"],"funding":["Klinbeforsk","Helse Vest","Helse Sør-Øst","REMEDY"],"pagination":["800"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11766089"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["26(2)"],"pubmed_abstract":["Chronic low back pain (cLBP) lacks clear physiological explanations, and the treatment options are of limited effect. We aimed to elucidate the underlying biology of cLBP in a subgroup of patients with Modic changes type I (suggestive of inflammatory vertebral bone marrow lesions) by correlating gene expression in blood with patient-reported outcomes on disability and pain intensity and explore sex differences. Patients were included from the placebo group of a clinical study on patients with cLBP and Modic changes. Blood was collected at the time of inclusion, after three months, and after one year, and gene expression was measured at all time points by high-throughput RNA sequencing. The patients reported disability using the Roland-Morris Disability Questionnaire, and pain intensity was"],"journal":["International journal of molecular sciences"],"pubmed_title":["Gene Expression Correlates with Disability and Pain Intensity in Patients with Chronic Low Back Pain and Modic Changes in a Sex-Specific Manner."],"pmcid":["PMC11766089"],"funding_grant_id":["Young researcher program","2017201","911938 and 911891","2015090"],"pubmed_authors":["Zwart JA","Zucknick M","Lie BA","Wigemyr M","Gjefsen E","The Aim Study Group","Storheim K","Flam ST","Pedersen LM","Braten LCH","Vigeland MD"],"additional_accession":[]},"is_claimable":false,"name":"Gene Expression Correlates with Disability and Pain Intensity in Patients with Chronic Low Back Pain and Modic Changes in a Sex-Specific Manner.","description":"Chronic low back pain (cLBP) lacks clear physiological explanations, and the treatment options are of limited effect. We aimed to elucidate the underlying biology of cLBP in a subgroup of patients with Modic changes type I (suggestive of inflammatory vertebral bone marrow lesions) by correlating gene expression in blood with patient-reported outcomes on disability and pain intensity and explore sex differences. Patients were included from the placebo group of a clinical study on patients with cLBP and Modic changes. Blood was collected at the time of inclusion, after three months, and after one year, and gene expression was measured at all time points by high-throughput RNA sequencing. The patients reported disability using the Roland-Morris Disability Questionnaire, and pain intensity was","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-19T18:22:03.616Z","creation":"2025-04-19T18:22:03.616Z"},"accession":"S-EPMC11766089","cross_references":{"pubmed":["39859512"],"doi":["10.3390/ijms26020800"]}}